Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Depreciation & Amortization (CF) (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Depreciation & Amortization (CF) data on record, last reported at $93000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 34.97% year-over-year to $93000.0; the TTM value through Sep 2025 reached $415000.0, down 67.4%, while the annual FY2024 figure was $1.0 million, 55.16% down from the prior year.
  • Depreciation & Amortization (CF) reached $93000.0 in Q3 2025 per FBIO's latest filing, down from $118000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $800000.0 in Q2 2022 and bottomed at $93000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $487789.5, with a median of $600000.0 recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 33.33% in 2022, then plummeted 73.47% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $700000.0 in 2021, then rose by 14.29% to $800000.0 in 2022, then tumbled by 52.88% to $377000.0 in 2023, then tumbled by 72.41% to $104000.0 in 2024, then dropped by 10.58% to $93000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $93000.0 in Q3 2025, $118000.0 in Q2 2025, and $100000.0 in Q1 2025.